Keyword: Baylor College of Medicine
The discovery that 500 cancers can be slotted into 10 subtypes, each of which is driven by a common set of proteins, could inspire new therapies.
Fierce 15 winner Kronos Bio has hired two new research program execs as it looks to put its recent funding haul to work.
A multi-institution research team has made several surprising discoveries about the role of proteins in colon cancer, which could inspire new treatments.
The week’s biotech news included an eFFECTOR drug that slows liver cancer in mice and insight into age-related muscle decline.
Diagnostic maker Echosens is teaming up with a consortium of health systems to develop a real-world evidence model to help standardize care for NASH.
Last week’s biotech discoveries include a gut-coating pill that lowers glucose and prostate-tumor test to predict a good response to immunotherapy.
The agreement will give TapImmune control of adoptive T-cell therapies designed to provide more durable responses than CAR-Ts.
The past week ushered in news about a toxin in scorpion venom that may relieve RA and a skin bacterium with anti-cancer powers.
CRISPR is a promising treatment for blood disorders, but it comes with challenges, such as off-target effects.
Scientists at Baylor have discovered that when they silence a signaling pathway in the body called Hippo, they can reverse heart failure in mice.